|
KMID : 0861120190230010083
|
|
Korean Journal of Oriental Preventive Medicine
2019 Volume.23 No. 1 p.83 ~ p.94
|
|
|
Effects of the mixed formulation of sorafenib and blue honeysuckle on the pharmacokinetics profiles of sorafenib
|
|
Kang Hyun-Gu
Kang Su-Jin
Ku Sae-Kwang
Choi Seong-Hun
Lee Young-Joon
|
|
|
Abstract
|
|
|
Objective : This study investigated the effects of concentrated and lyophilized blue honeysuckle powders (BH) on the pharmacokinetics (PK) of sorafenib were observed.
Method : The blood was collected at 0.5 hr before single oral treatment of sorafenib (40 mg/kg) or sorafenib with BH (400, 200 and 100 mg/kg) mixed formulas administration, and 0.5, 1, 2, 3, 4, 6, 8 and 24 hrs after the end of single or mixed formula administration. Plasma concentrations of sorafenib were analyzed using LC-MS/MS methods. Tmax, Cmax, AUC, t1/2 and MRTinf of sorafenib were analysis as compared with sorafenib single treatment.
Results : Single oral administration of mixed formulas induced significant increases of plasma sorafenib concentrations from 0.5 hr after end of administration throughout all blood collected time points, as compared with sorafenib single formula treated rats, and significant decreases of sorafenib Tmax with increases of Cmax, AUC0-t and AUC0-inf were detected in sorafenib and BH 400 mg/kg mixed formulation treated rats as compared with sorafenib single formula treated rats, respectively. Inaddition, sorafenib and BH 200 or 100 mg/kg mixed formula treated rats also showed significant increases of sorafenib Cmax, AUC0-t and AUC0-inf, respectively.
Conclusions : According to these results, mixed formulation of BH with sorafenib increased the bioavailability of sorafenib through the increment of the absorptions.
|
|
|
KEYWORD
|
|
|
Blue honeysuckle, Hepatic cancer, Pharmacokinetics, Drug-drug interactions, Rat, Sorafenib
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|